Publicação
Private equity challenge - compugroup medical se - due diligence and a successful exit
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | Duarte, Luís Mota | |
| dc.contributor.advisor | Santos, Fábio | |
| dc.contributor.author | Bayer, Wenzel Bartolo | |
| dc.date.accessioned | 2024-10-23T08:14:04Z | |
| dc.date.available | 2024-10-23T08:14:04Z | |
| dc.date.issued | 2024-01-10 | |
| dc.date.submitted | 2023-12-29 | |
| dc.description.abstract | This paper examines the acquisition of CompuGroup Medical SE & Co. KGaA, a German healthcare software IT company. In an investment committee paper, we analyze the target, the healthcare IT market, and how we can create value by acquiring CGM. This paper explains why we want to invest in CGM, how we want to create additional value, and what implications this has both, strategically and financially. The group part of this document comprises an executive summary, while the individual parts contain deep dives on the created value creation strategy, valuation, leveraged buyout impact, due diligence, and exit. | pt_PT |
| dc.identifier.tid | 203604520 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/173922 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | UID/ECO/00124/2013 | pt_PT |
| dc.subject | Private equity | pt_PT |
| dc.subject | Software | pt_PT |
| dc.subject | Leveraged buyout | pt_PT |
| dc.subject | Exit strategy | pt_PT |
| dc.subject | Value creation | pt_PT |
| dc.subject | Due diligence | pt_PT |
| dc.subject | Healthcare | pt_PT |
| dc.title | Private equity challenge - compugroup medical se - due diligence and a successful exit | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Master’s degree in Finance from the Nova School of Business and Economics. | pt_PT |